Hawthorn (Crataegus spp.) in the treatment of cardiovascular disease - PubMed (original) (raw)
Hawthorn (Crataegus spp.) in the treatment of cardiovascular disease
Mary C Tassell et al. Pharmacogn Rev. 2010 Jan.
Abstract
The medicinal properties of hawthorn (Crataegus spp., a genus comprising approximately 300 species) have been utilized by many cultures for a variety of therapeutic purposes for many centuries. In the Western world cardiovascular disease (CVD) has become one of the single most significant causes of premature death. Echoing this situation, more recent research into the therapeutic benefits of hawthorn preparations has focused primarily upon its cardiovascular effects. This review covers research into the various mechanisms of action proposed for Crataegus preparations, clinical trials involving Crataegus preparations, and the herb's safety profile.Clinical trials reviewed have been inconsistent in terms of criteria used (sample size, preparation, dosage, etc) but have been largely consistent with regard to positive outcomes. An investigation into data available to date regarding hawthorn preparations and herb/drug interactions reveals that theoretical adverse interactions have not been experienced in practice. Further, adverse reactions relating to the use of hawthorn preparations are infrequent and mild, even at higher dosage ranges. A recent retrospective study by Zick et al. has suggested a negative outcome for the long-term use of hawthorn in the prognosis of heart failure. These findings are examined in this paper.Although further research is needed in certain areas, current research to date suggests that hawthorn may potentially represent a safe, effective, nontoxic agent in the treatment of CVD and ischemic heart disease (IHD).
Keywords: Cardiovascular disease; Crataegus; hawthorn; whitethorn.
Conflict of interest statement
Conflict of Interest: None declared
Similar articles
- Adverse-event profile of Crataegus spp.: a systematic review.
Daniele C, Mazzanti G, Pittler MH, Ernst E. Daniele C, et al. Drug Saf. 2006;29(6):523-35. doi: 10.2165/00002018-200629060-00005. Drug Saf. 2006. PMID: 16752934 Review. - Traditional uses, phytochemistry, pharmacology, and safety concerns of hawthorn (Crataegus genus): A comprehensive review.
Cui M, Cheng L, Zhou Z, Zhu Z, Liu Y, Li C, Liao B, Fan M, Duan B. Cui M, et al. J Ethnopharmacol. 2024 Jan 30;319(Pt 2):117229. doi: 10.1016/j.jep.2023.117229. Epub 2023 Oct 1. J Ethnopharmacol. 2024. PMID: 37788786 Review. - Potential Roles and Key Mechanisms of Hawthorn Extract against Various Liver Diseases.
Kim E, Jang E, Lee JH. Kim E, et al. Nutrients. 2022 Feb 18;14(4):867. doi: 10.3390/nu14040867. Nutrients. 2022. PMID: 35215517 Free PMC article. Review. - Hawthorn: pharmacology and therapeutic uses.
Rigelsky JM, Sweet BV. Rigelsky JM, et al. Am J Health Syst Pharm. 2002 Mar 1;59(5):417-22. doi: 10.1093/ajhp/59.5.417. Am J Health Syst Pharm. 2002. PMID: 11887407 Review.
Cited by
- Anti-hypertensive Herbs and their Mechanisms of Action: Part I.
Al Disi SS, Anwar MA, Eid AH. Al Disi SS, et al. Front Pharmacol. 2016 Jan 19;6:323. doi: 10.3389/fphar.2015.00323. eCollection 2015. Front Pharmacol. 2016. PMID: 26834637 Free PMC article. Review. - Crataegus laevigata Suppresses LPS-Induced Oxidative Stress during Inflammatory Response in Human Keratinocytes by Regulating the MAPKs/AP-1, NFκB, and NFAT Signaling Pathways.
Nguyen QTN, Fang M, Zhang M, Do NQ, Kim M, Zheng SD, Hwang E, Yi TH. Nguyen QTN, et al. Molecules. 2021 Feb 6;26(4):869. doi: 10.3390/molecules26040869. Molecules. 2021. PMID: 33562140 Free PMC article. - Polyphenolic profile and biological activity of Chinese hawthorn (Crataegus pinnatifida BUNGE) fruits.
Jurikova T, Sochor J, Rop O, Mlcek J, Balla S, Szekeres L, Adam V, Kizek R. Jurikova T, et al. Molecules. 2012 Dec 6;17(12):14490-509. doi: 10.3390/molecules171214490. Molecules. 2012. PMID: 23222867 Free PMC article. Review. - In Vitro Anti-cancer Effect of Crataegus oxyacantha Berry Extract on Hormone Receptor Positive and Triple Negative Breast Cancers via Regulation of Canonical Wnt Signaling Pathway.
Kombiyil S, Sivasithamparam ND. Kombiyil S, et al. Appl Biochem Biotechnol. 2023 Apr;195(4):2687-2708. doi: 10.1007/s12010-021-03724-4. Epub 2022 Mar 9. Appl Biochem Biotechnol. 2023. PMID: 35262883 - Water-Based Extraction of Bioactive Principles from Blackcurrant Leaves and Chrysanthellum americanum: A Comparative Study.
Cao-Ngoc P, Leclercq L, Rossi JC, Hertzog J, Tixier AS, Chemat F, Nasreddine R, Al Hamoui Dit Banni G, Nehmé R, Schmitt-Kopplin P, Cottet H. Cao-Ngoc P, et al. Foods. 2020 Oct 16;9(10):1478. doi: 10.3390/foods9101478. Foods. 2020. PMID: 33081198 Free PMC article.
References
- Albarouki E, Peterson A. Molecular and morphological characterization of Crataegus L. species (Rosaceae) in southern Syria. Botanical Journal of the Linnean Society. 2007
- British HF. British Heart Foundation. Statistics. 2006. Nov 3rd, [cited in 2007]. Available from: http://www.heartstats.org/datapage.asp?id=713 .
- World HO. World Health Organisation Website. [cited in 2007]. Available from: http://www.who.int/topics/cardiovascular_diseasees/en/.
- National S. Heart disease leading cause of death in England and Wales. Health Statistics Quarterly. 2006
- Bournemouth: British Herbal Medicines Association; 1984. Herbal Medicines Association, B., British Herbal Pharmacopoeia.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous